3 results
Approved WMOWill not start
The aim of this pilotstudy is to obtain data regarding feasibility, safety and costs of home-based electrical cardioversion
Approved WMORecruiting
The purpose of this study is to evaluate the efficacy and safety of MDV3100, a novel potent androgen-receptor antagonist without known agonist activity, in asymptomatic or mildly symptomatic patients with progressive metastatic prostate cancer who…
Approved WMOPending
1. To assess the effects of 3 months neoadjuvant androgen ablation with enzalutamide on the surgicial margin status of men with non-metastasized prostate cancer.2. To properly evaluate the effects of androgen ablation on gene expression, analyses of…